| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/05/2007 | WO2007038036A1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 04/05/2007 | WO2007037886A2 Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear |
| 04/05/2007 | WO2007037874A2 Methods for treatment and prevention of otitis media using chemical penetration enhancers to facilitate transmembrane drug delivery into the middle ear |
| 04/05/2007 | WO2007037803A2 Water-soluble colonoscopy lubricant |
| 04/05/2007 | WO2007037782A2 Method for treating prostate conditions |
| 04/05/2007 | WO2007037746A1 Use of a composition comprising an antacid, a mucolytic an a gelling agent in the treatment of cold. |
| 04/05/2007 | WO2007037743A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia |
| 04/05/2007 | WO2007037742A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia |
| 04/05/2007 | WO2007037685A1 Novel antibiotics comprising bis(1-aryl-5-tetraz0lyl)methane derivatives |
| 04/05/2007 | WO2007037666A1 Pharmaceutical form containing methocarbamol, meloxicam and betamethasone |
| 04/05/2007 | WO2007037665A1 Preparation for the treatment of inflammatory skin diseases, containing tacrolimus |
| 04/05/2007 | WO2007037627A1 Pharmaceutical composition comprising polysaccharides from angelica gigas nakai for prevention and treatment of cancer disease |
| 04/05/2007 | WO2007037598A1 Anti-cancer activity of androsace umbellata merr. extract and contained triterpene saponin |
| 04/05/2007 | WO2007037560A1 Therapeutic or diagnostic application of sgk2 gene |
| 04/05/2007 | WO2007037555A1 Therapeutic or diagnostic application of dusp15 gene |
| 04/05/2007 | WO2007037554A1 Adsorbent for advanced glycation endproducts |
| 04/05/2007 | WO2007037550A1 Therapeutic or diagnostic application of tsta3 gene |
| 04/05/2007 | WO2007037543A1 Biarylamide derivative |
| 04/05/2007 | WO2007037538A1 Therapeutic or diagnostic application of spo11 gene |
| 04/05/2007 | WO2007037534A1 2-heteroaryl-substituted indole derivative |
| 04/05/2007 | WO2007037533A1 Therapeutic or diagnostic application of ppp1r3d gene |
| 04/05/2007 | WO2007037532A1 Therapeutic or diagnostic application of srms gene |
| 04/05/2007 | WO2007037518A1 Mutilin derivative and pharmaceutical composition containing the same |
| 04/05/2007 | WO2007037513A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 04/05/2007 | WO2007037473A1 Method of inhibiting cell migration and cell migration inhibitor |
| 04/05/2007 | WO2007037438A1 Ameliorating agent for metabolic syndrome |
| 04/05/2007 | WO2007037423A1 Antidiabetic agent |
| 04/05/2007 | WO2007037333A1 Inhibitor of binding to non-typical proline-rich sequence |
| 04/05/2007 | WO2007037330A1 Method for production of quinolone-containing lyophilized preparation |
| 04/05/2007 | WO2007037296A1 Medical agent containing insulin resistance improving agent |
| 04/05/2007 | WO2007037295A1 Wrinkling prevention or mitigation with adam inhibitor |
| 04/05/2007 | WO2007037259A1 Pulse preparation having improved disintegration properties in vivo |
| 04/05/2007 | WO2007037258A1 Therapeutic agent for attention deficit/hyperactivity disorder |
| 04/05/2007 | WO2007037249A1 Cellooligosaccharide-containing composition |
| 04/05/2007 | WO2007037188A1 Pharmaceutical for prevention and treatment of ophthalmic disease induced by increase in vasopermeability |
| 04/05/2007 | WO2007037187A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/05/2007 | WO2007037060A1 Composition for acceleration of type i collagen production |
| 04/05/2007 | WO2007037010A1 Phenoxyacetic acid derivatives and drugs using the same |
| 04/05/2007 | WO2007036947A1 Delayed release anti-malarial composition |
| 04/05/2007 | WO2007036945A2 Hepatocyte growth factor receptor splice variants and methods of using same |
| 04/05/2007 | WO2007036920A2 Therapeutic use of polyanhydroglucronic acid |
| 04/05/2007 | WO2007036791A1 Pyrido-pyridimidine derivatives useful as antiinflammatory agents |
| 04/05/2007 | WO2007036781A1 Diphenyl ether monoamine reuptake inhibitor |
| 04/05/2007 | WO2007036769A1 Aminothiazole derivatives as agonists of the thrombopoietin receptor |
| 04/05/2007 | WO2007036743A2 Quinolines and their therapeutic use |
| 04/05/2007 | WO2007036734A1 Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor |
| 04/05/2007 | WO2007036733A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 04/05/2007 | WO2007036732A1 Imidazo [1,2-a] pyridine having anti-cell-proliferation activity |
| 04/05/2007 | WO2007036730A1 Thiophene derivatives as ppar agonists i |
| 04/05/2007 | WO2007036727A1 Condensed pyrazole derivatives as ppar agonists ii |
| 04/05/2007 | WO2007036718A2 Compounds which have activity at m1 receptor and their uses in medicine |
| 04/05/2007 | WO2007036717A1 4- (4-BROMO-2-FLUOROANILINO) -6-METHOXY-7- (l-METHYLPIPERIDIN-4 -YLMETHOXY) QUINAZOLINE MONOHYDRATE |
| 04/05/2007 | WO2007036715A2 Compounds which have activity at m1 receptor and their uses in medicine |
| 04/05/2007 | WO2007036711A1 BENZIMIDAZOLONES WHICH HAVE ACTIVITY AT Ml RECEPTOR |
| 04/05/2007 | WO2007036688A1 Pharmaceutically acceptable salts and hydrates of risedronic acid |
| 04/05/2007 | WO2007036671A2 Microparticles with modified release of at least one active principle and oral galenic form comprising same |
| 04/05/2007 | WO2007036599A1 New crystallization process of quetiapine hemifumarate |
| 04/05/2007 | WO2007036543A1 Beta-3-agonist use for treating kidney and bladder troubles of a patient with spinal cord damages |
| 04/05/2007 | WO2007036376A2 Skincare products |
| 04/05/2007 | WO2007036363A2 Compositions containing butyric acid ester of carbohydrates and carbohydrate polyols |
| 04/05/2007 | WO2007036306A1 2-aminoethoxyacetic acid derivatives and their use in treating thromboembolic disorders |
| 04/05/2007 | WO2007036138A1 5H-THIENO [3,4-c] PYRROLE-4, 6-DIONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR |
| 04/05/2007 | WO2007036131A1 Carzole sulphamide derivatives and their preparation method |
| 04/05/2007 | WO2007036113A1 Medical use of periplocoside a and e |
| 04/05/2007 | WO2007036083A1 Indolyl acrylic derivatives and usage in preparation of immunosuppressive agent thereof |
| 04/05/2007 | WO2007036074A1 The use of phthalide derivatives |
| 04/05/2007 | WO2007036053A1 Inhibitors of ste20-like kinase (slk) and methods of modulating cell cycle progression and cell motility |
| 04/05/2007 | WO2007036044A1 Combination of polychitosamine and fibrate for the prevention and treatment of hyperlipidemia |
| 04/05/2007 | WO2007036041A1 Sialidase inhibitors for the treatment of cardiovascular disease |
| 04/05/2007 | WO2007036036A1 Method and composition for increasing the engraftment efficiency of stem cells |
| 04/05/2007 | WO2007036029A1 Aerosol powder formulation comprising sieved lactose |
| 04/05/2007 | WO2007036028A1 Compositions for and methods of granzyme b inhibition |
| 04/05/2007 | WO2007036022A1 Targeted delivery of compounds using multimerization technology |
| 04/05/2007 | WO2007036016A1 Therapeutic molecules and their uses |
| 04/05/2007 | WO2007022384A3 Pyrazine kinase inhibitors |
| 04/05/2007 | WO2007021825A3 Treatment of proliferative disorders |
| 04/05/2007 | WO2007021575A3 Acetylenic piperazines as metabotropic glutamate receptor antagonists |
| 04/05/2007 | WO2007019234A3 Aminoethane sulfonamide orexin receptor antagonists |
| 04/05/2007 | WO2007017513A3 Formulations for 7-(t-butoxy)iminomethyl camptothecin |
| 04/05/2007 | WO2007016287A9 Pdt treatment method for cellulites and cosmetic use |
| 04/05/2007 | WO2007016139A3 Crystalline non-solvated methanesulfonic acid salt of 1-(4-(2-piperidinylethoxy)phenoxy)-2-(3-hydroxyphenyl)-6-hydroxynaphthalene |
| 04/05/2007 | WO2007016012A3 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION |
| 04/05/2007 | WO2007015003A3 Novel crystalline iii form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 04/05/2007 | WO2007014934A3 Quinoline derivatives as antibacterial agents |
| 04/05/2007 | WO2007014934A2 Quinoline derivatives as antibacterial agents |
| 04/05/2007 | WO2007013975A3 Composition containing an opioid agonist and a partial opioid agonist, preferably buprenorphine , for controlling abuse of medications |
| 04/05/2007 | WO2007012972A3 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them |
| 04/05/2007 | WO2007012972A2 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them |
| 04/05/2007 | WO2007011762A3 Jnk inhibitors for the treatment of endometreosis |
| 04/05/2007 | WO2007010504A3 Acid addition salts of isoindoles acting as adrenergic receptor antagonists |
| 04/05/2007 | WO2007010084A3 Immunostimulatory oligo- and polysaccharides and uses thereof |
| 04/05/2007 | WO2007009806A3 Solid dosage formulations of narcotic drugs having improved buccal adsorption |
| 04/05/2007 | WO2007009724A3 Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/05/2007 | WO2007009723A3 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/05/2007 | WO2007009700A3 Use of substituted pyrazoline compounds for the treatment of the lipid parameters of the metabolic syndrome |
| 04/05/2007 | WO2007007982A3 Glucose uptake modulator and method for treating diabetes or diabetic complications |
| 04/05/2007 | WO2007007982A2 Glucose uptake modulator and method for treating diabetes or diabetic complications |
| 04/05/2007 | WO2007006922A3 Novel 1h-indole-pyridinecarboxamide derivatives and 1h-indole-piperidinecarboxamide and their use as hydroxylase tyrosine inducers |
| 04/05/2007 | WO2007005758A3 Methods , compositions and devices for promoting angiogenesis |
| 04/05/2007 | WO2007002884A3 4-fluoro-piperidine t-type calcium channel antagonists |